-
-
Shanghai Fosun Pharmaceutical（Group）Co., Ltd.
XPHOZAH®
Common Name：Tenapanor Hydrochloride Tablets
XPHOZAH®（Tenapanor Hydrochloride Tablets）is the world's first phosphate absorption inhibitor that inhibits the intestinal epithelial sodium-hydrogen exchanger 3 and blocks paracellular phosphate absorption to reduce serum phosphorus levels. It is indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy. XPHOZAH® has a novel mechanism of action and can effectively reduce phosphorus levels when used alone or in combination with phosphate binders, increasing the rate of achieving target serum phosphorus levels, significantly reducing the pill burden for patients, improving bowel movements, and demonstrating good long-term safety. XPHOZAH® was approved in mainland China on February 20, 2025, and was approved for the treatment of hyperphosphatemia in Japan and the United States in 2023.
-
-
Wanbang Biopharmaceuticals
You Li Tong
Common Name：Febuxostat Tablets
For the long-term treatment of hyperuricemia with the symptom of gout. It is not recommended for asymptomatic hyperuricemia.
-
-
YaoPharma Co., Ltd.
Atomolan Injection
Common Name：Reduced Glutathione for Injection
This is with formulation patent and comprehensive dosage forms and strengths; category B product covered in National Reimbursement Drug List; recommended drug in multiple guidelines and clinical paths, and essential medicine for liver disease treatment.
-
-
YaoPharma Co., Ltd.
Atomolan Tablets
Common Name：Glutathione Tablets
The first oral preparation of glutathione in China; category B product covered in National Reimbursement Drug List; recommended drug in multiple guidelines and clinical paths, and essential medicine for liver disease treatment.
-
-
Shanghai Chemo Wanbang Biopharma Co., Ltd.
Yi Bao
Common Name：Human Erythrotropin for Injection
For treatment of anemia caused by renal insufficiency, including chronic renal failure in hemodialysis, peritoneal dialysis, and non-dialysis patients
-
-
Hebei Wanbang Folon Pharmaceutical Co., Ltd.
Ke Yi
Common Name：Compound Aloe Capsules
For hyperactivity of heart-liver heat, constipation, abdominal distension
-
-
YaoPharma Co., Ltd.
Fan Ke Jia
Common Name：Lipoic Acid Injection
Category B product covered in National Reimbursement Drug List. Endogenous substance, soluble in lipid and water, high safety. This product is recommended in multiple guidelines and consensuses and is the common medicine for treatment of diabetic peripheral neuropathy.
-
-
Wanbang Biopharmaceuticals
Wan Su Ping
Common Name：Glimepride Tablets
For treatment of type II diabetes, where diet control, exercise and weight loss cannot fully control blood glucose.
-
-
YaoPharma Co., Ltd.
Li Qing
Common Name：Alfacalcidol Tablets
Listed in the National Essential Medicines List, National Reimbursement Drug List (Category B) and National Centralized Drug Procurement List.Essential medicine for treatment and prevention of osteoporosis.
-
-
YaoPharma Co., Ltd.
倍逸
Common Name：Potassium Chloride Granules
Listed in the National Essential Medicines List, National Reimbursement Drug List (Category A). recommended in multiple guidelines and consensuses as the first-line therapy drug for the prevention and treatment of hypokalemia. It is used for the treatment and prevention of hypokalemia with or without metabolic alkalosis when dietotherapy with potassium-rich foods or diuretic dose reduction present poor effect.